Etid klinik pou Amiloidoz nan Maryland
7 etid pou Amiloidoz ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 23, 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Baltimore
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 16, 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Baltimore
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 15, 2026 · NCT07223203ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Baltimore
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 8, 2026 · NCT04561518Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Maryland Medical Center, Baltimore
- Johns Hopkins University, Baltimore
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou May 19, 2026 · NCT06974877MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Johns Hopkins University, Baltimore
Ap rekriteFaz 3
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.